Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Cancer Treatment and Research Communications|March 25, 2025
The prognostic role of circulating CA19-9 and CEA in patients with colorectal cancerMathias H Gramkow, Camilla S Mosgaard, Jakob V Schou, et al.International Journal of Cancer|January 3, 2023
Therapy with pembrolizumab in treatment-naïve patients with nonmetastatic, mismatch repair deficient colorectal cancerRikke Løvendahl Eefsen, Jim S Larsen, Louise L Klarskov, et al.Technology in Cancer Research & Treatment|March 12, 2015
The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?Berardino De Bari, Pierfrancesco Franco, Maximilian Niyazi, et al.Annals of Surgery|November 11, 2024
Postoperative Exercise Training in Patients with Colorectal Liver Metastases A Randomized Controlled TrialSimon Nørskov Thomsen, Rikke Krabek, Christina Yfanti, et al.Molecular Oncology|March 20, 2013
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancerMads H Rasmussen, Niels F Jensen, Line S Tarpgaard, et al.Oncotarget|June 2, 2016
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancerArtur Mezheyeuski, Maja Bradic Lindh, Tormod Kyrre Guren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2024
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 StudyAkihito Kawazoe, Rui-Hua Xu, Pilar García-Alfonso, et al.Plos One|October 21, 2014
Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without BevacizumabMogens K Boisen, Christian Dehlendorff, Dorte Linnemann, et al.Nature Medicine|April 20, 2026
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trialIgnacio Melero, Tamara Tanos, Emiliano Calvo Aller, et al.ESMO Open|February 22, 2018
Global cancer control: responding to the growing burden, rising costs and inequalities in accessGerald W Prager, Sofia Braga, Branislav Bystricky, et al.Pageof 7